Ginsenoside compound K suppresses the abnormal activation of T lymphocytes in mice with collagen-induced arthritis

Acta Pharmacologica Sinica

Volumn 35, Issue 5, 2014, Pages 599-612

  Liu, Kang Kang ^a   Wang, Qing Tong ^a   Yang, Si Min ^a   Chen, Jing Yu ^a   Wu, Hua Xun ^a   Wei, Wei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

arthritis; CD28; cytokine; cytotoxic T lymphocyteassociated antigen 4; ginseng; ginsenoside compound K; immunoregulator; programmed death 1; T lymphocyte

Indexed keywords

ANTIRHEUMATIC AGENT; CD28 ANTIGEN; COLLAGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GINSENOSIDE; GINSENOSIDE COMPOUND K; IMMUNOMODULATING AGENT; INTERLEUKIN 4; METHOTREXATE; PROGRAMMED DEATH 1 LIGAND 1; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; CD3 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PDCD1 PROTEIN, MOUSE; PROGRAMMED DEATH 1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; WESTERN BLOTTING; ANIMAL; ARTHRITIS, EXPERIMENTAL; CELL PROLIFERATION; CHEMICALLY INDUCED; DBA MOUSE; DRUG EFFECTS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; SPLEEN; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD3; ARTHRITIS, EXPERIMENTAL; B-LYMPHOCYTES; CELL PROLIFERATION; COLLAGEN; CTLA-4 ANTIGEN; GINSENOSIDES; INTERFERON-GAMMA; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED DBA; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, ANTIGEN, T-CELL; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84927713785     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2014.5     Document Type: Article

References (49)

1. Smolen JS, Aletaha D. Developments in the clinical understanding of rheumatoid arthritis. Arthritis Res Ther 2009; 11: 204
2. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet 2007; 370: 1861-74
3. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 7: 429-42
4. Schulze-Koops H, Kalden JR. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2001; 15: 677-91
5. Leah E. Rheumatoid arthritis: Metabolic reprogramming of T cells in RA. Nat Rev Rheumatol 2013; 9: 635
6. Boissier MC, Semerano L, Challal S, Saidenberg-Kermanac'h N, Falgarone G. Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction. J Autoimmun 2012; 39: 222-8
7. Kaufmann DE, Walker BD. PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J Immunol 2009; 182: 5891-7
8. Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 2013; 13: 227-42
9. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004; 4: 336-47
10. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005; 23: 515-48
11. Brownlie RJ, Zamoyska R. T cell receptor signalling networks: branched, diversified and bounded. Nat Rev Immunol 2013; 13: 257-69
12. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol 2006; 24: 65-97
13. Snauwaert S, Verstichel G, Bonte S, Goetgeluk G, Vanhee S, Van Caeneghem Y, et al. In vitro generation of mature, naive antigenspecific CD8+ T cells with single T cell receptor by agonist selection. Leukemia 2013 Oct 4. doi: 10.1038/leu.2013.285
14. Lan KH, Liu YC, Shih YS, Tsaid CL, Yen SH, Lan KL. A DNA vaccine against cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) prevents tumor growth. Biochem Biophys Res Commun 2013; 440: 222-8
15. Im DS, Nah SY. Yin and Yang of ginseng pharmacology: ginsenosides vs gintonin. Acta Pharmacol Sin 2013; 34: 1367-73
16. Bae J, Koo J, Kim S, Park TY, Kim MY. Ginsenoside Rp1 exerts antiinflammatory effects via activation of dendritic cells and regulatory T cells. J Ginseng Res 2012; 36: 375-82
17. Shi J, Xue W, Zhao WJ, Li KX. Pharmacokinetics and dopamine/acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats. Acta Pharmacol Sin 2013; 34: 214-20
18. Mochizuki M, Yoo YC, Matsuzawa K, SatoK, Saiki I, Tono-oka S, Samukawa K, et al. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)-And 20(S)-ginsenoside-Rg3 of red ginseng. Biol Pharm Bull 1995; 18: 1197-202
19. Sun J, Song X, Hu S. Ginsenoside Rg1 and aluminum hydroxide synergistically promote immune responses to ovalbumin in BALB/c mice. Clin Vaccine Immunol 2008; 15: 303-7
20. Kim JS, Kim Y, Han SH, Jeon JY, Hwang M, Im YJ, et al. Development and validation of an LC-MS/MS method for determination of compound K in human plasma and clinical application. J Ginseng Res 2013; 37: 135-41
21. Quan LH, Piao JY, Min JW, Yang DU, Lee HN, Yang DC. Bioconversion of ginsenoside Rb1 into compound K by Leuconostoccitreum LH1 isolated from kimchi. Braz J Microbiol 2011; 42: 1227-37
22. Cho SH, Chung KS, Choi JH, Kim DH, Lee KT. Compound K, a metabolite of ginseng saponin, induces apoptosis via caspase-8-dependent pathway in HL-60 human leukemia cells. BMC Cancer 2009; 9: 449
23. Choi KT. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin 2008; 29: 1109-18
24. Choo MK, Sakurai H, Kim DH, Saiki I. A ginseng saponin metabolite suppresses tumor necrosis factor-promoted metastasis by suppressing nuclear factor-B signaling in murine colon cancer cells. Oncol Rep 2008; 19: 595-600
25. Kim DY, Yuan HD, Chung IK, Chung SH. Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells. J Agric Food Chem 2009; 57: 1532-7
26. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 1977; 146: 857-68
27. Brand DD, Kang AH, Rosloniec EF. Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol 2003; 25: 3-18
28. Huang B, Wang QT, Song SS, Wu YJ, Ma YK, Zhang LL, et al. Combined use of etanercept and MTX restores CD4+/CD8+ ratio and Tregs in spleen and thymus in collagen-induced arthritis. Inflamm Res 2012; 61: 1229-39
29. Tong T, Zhao W, Wu YQ, Chang Y, Wang QT, Zhang LL, et al. Chicken type II collagen induced immune balance of main subtype of helper T cells in mesenteric lymph node lymphocytes in rats with collageninduced arthritis. Inflamm Res 2010; 59: 369-77
30. Wang QT, Wu YJ, Huang B, Ma YK, Song SS, Zhang LL, et al. Etanercept attenuates collagen-induced arthritis by modulating the association between BAFFR expression and the production of splenic memory B cells. Pharmacol Res 2013; 68: 38-45
31. DibraD, CutreraJJ, Li S. Coordination between TLR9 signaling in macrophages and CD3 signaling in T cells induces robust expression of IL30. J Immunol 2012; 188: 3709-15
32. Wu HX, Chen JY, Wang QT, Sun WY, Liu LH, Zhang LL, et al. Expression and function of-Arrestin 2 stimulated by IL-1? in human fibroblastlike synoviocytes and the effect of paeoniflorin. Int Immunopharmacol 2012; 12: 701-6
33. Wang QT, Ma YK, Huang B, Liu DD, Wei W. Effect of rhTACI-Ig fusion protein on antigen-specific T cell responses from keyhole limpet haemocyanin challenged mice. Mol Immunol 2011; 49: 380-6
34. Sakaguchi S, Benham H, Cope AP, Thomas R. T-cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man. Immunol Cell Biol 2012; 90: 277-87
35. Wang QT, Zhang LL, Wu HX, Wei W. The expression change of-Arrestins in fibroblast-like synoviocytes from rats with collageninduced arthritis and the effect of total glucosides of paeony. J Ethnopharmacol 2011; 133: 511-6
36. Cope AP, Schulze-Koops H, Aringer M. The central role of T cells in rheumatoid arthritis. Clin Exp Rheumatol 2007; 25: S4-11
37. Skapenko A, Leipe J, Lipsky PE, Schulze-Koops H. The role of the T cell in autoimmune inflammation. Arthritis Res Ther 2005; 2: S4-14
38. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 7: 429-42
39. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF? therapy. J Exp Med 2004; 200: 277-85
40. Lee EJ, Ko E, Lee J, Pho S, Ko S, Shin MK, et al. Ginsenoside Rg1 enhances CD4+ T-cell activities and modulates Th1/Th2 differentiation. Int Immunopharmacol 2004; 4: 235-44
41. Shin YW, Bae EA, Kim SS, Lee YC, Kim DH. Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis. Int Immunopharmacol 2005; 5: 1183-91
42. Wu H, Wei W, Song L, Zhang L, Chen Y, Hu X. Paeoniflorin induced immune tolerance of mesenteric lymph node lymphocytes via enhancing beta 2-Adrenergic receptor desensitization in rats with adjuvant arthritis. Int Immunopharmacol 2007; 7: 662-73
43. Li Q, Shen HH. Neonatal bacillus Calmette-Guerin vaccination inhibits de novo allergic inflammatory response in mice via alteration of CD4+CD25+ T-regulatory cells. Acta Pharmacol Sin 2009; 30: 125-33
44. Bacchetta R, Gambineri E, Roncarolo MG. Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol 2007; 120: 227-35
45. Klimiuk PA, Yang H, Goronzy JJ, Weyand CM. Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent. Clin Immunol 1999; 90: 65-78
46. Brownlie RJ, Zamoyska R. T cell receptor signalling networks: branched, diversified and bounded. Nat Rev Immunol 2013; 13: 257-69
47. Jerome KR. Viral modulation of T-cell receptor signaling. J Virol 2008; 82: 4194-204
48. Riley JL, June CH. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 2005; 105: 13-21
49. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol 2006; 24: 65-97